Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Appeals court blocks Trump from firing FTC commissioner...
House Oversight Committee releases thousands of Epstein documents
Senate advances defense bill boosting service member pay,...
Trump claims Putin, Xi, Kim are conspiring against...
Elon Musk opines on ‘major driver of white...
It’s not the economy, stupid. Democrats’ real path...
More than 1,000 HHS workers demand Kennedy resignation...
Rashida Tlaib hit with House censure threat, accused...
Xi Jinping hails ‘unstoppable’ China as Trump accuses...
Trump welcomes Polish president with flyover tribute to...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

Russia Restricts US Uranium Exports, Retaliating to American Ban

by admin November 19, 2024
November 19, 2024
Russia Restricts US Uranium Exports, Retaliating to American Ban

The Russian government has imposed temporary restrictions on enriched uranium exports to the US.

Announced on November 15, the move follows the US’ decision toban imports of Russian uranium.

While the US legislation went into effect in August, it allows for waivers to address potential supply disruptions through 2027. The new Russian policy introduces uncertainty during this time period.

According to the US Energy Information Administration, Russia provided 27 percent of the enriched uranium used in American reactors in 2023. Globally, the country accounts for about 44 percent of enrichment capacity.

To illustrate, Urenco — a consortium-owned company operating the only US-based enrichment facility in New Mexico — supplies only about one-third of the country’s enriched uranium.

While the restrictions from Russia don’t leave the US without recourse, as utilities typically secure uranium supply years in advance, analysts are warning that continued restrictions could pose challenges from 2025 onward.

Market responses to the news were swift. Cameco (TSX:CCO,NYSE:CCJ), a leading uranium producer, emphasized in a statement to Bloomberg the need for coordinated western action to reduce reliance on Russian nuclear fuel.

Shares of uranium companies reflected the heightened supply concerns, with Cameco’s share price jumping as much as 6.5 percent on the TSX on November 15. US-based uranium firms such as Uranium Energy (NYSEAMERICAN:UEC) and Ur-Energy (TSX:URE,NYSEAMERICAN:URG) also experienced upticks that day.

Meanwhile, shares of Centrus Energy (NYSEAMERICAN:LEU), the biggest US trader of Russian enriched uranium, fell by close to 9 percent on November 15 as investors weighed the potential impacts of the restrictions.

The company said it had not received details surrounding Russia’s decree and was assessing the implications.

Centrus also noted that it has contingency plans to mitigate near-term impacts should Russia’s state-owned uranium supplier, Tenex, face challenges fulfilling existing agreements. Centrus is one company that has received a waiver from the Biden administration to continue importing Russian uranium despite the US ban.

Constellation Energy (NASDAQ:CEG) has also received a waiver, and other requests are reportedly pending.

Russia’s actions come amid broader geopolitical tensions and follow President Vladimir Putin’s earlier call for the country to consider restricting exports of uranium, titanium and nickel in response to western sanctions.

At the same time, the US government has been actively working to rebuild its uranium enrichment capabilities. A multibillion-dollar initiative to expand these operations is underway, but progress has been slow.

Overall, the US is currently looking triple its nuclear capacity by 2050, with plans to add 200 gigawatts of new nuclear energy through reactor builds, reactivations and upgrades to existing facilities.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Mawson Finland Limited Presents Downhole EMGeophysics: Multiple Deep Conductors Newly Identified at Rajapalot
next post
Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types

You may also like

Top 5 Small-cap Pharma Stocks of 2025

August 16, 2025

Condor Energies Secures Second Critical Minerals Mining License...

March 12, 2025

Mawson Finland Begins 2025 Drill Program, Mobilizing Multiple...

January 15, 2025

Silver Crown Royalties

August 1, 2024

Charbone Hydrogen Secures Key Transport Infrastructure for Green...

July 24, 2024

US Capital Gains Tax Guide for Gold and...

April 18, 2025

Hazer and KBR Enter Global Deal to Accelerate...

May 5, 2025

Gary Wagner: Gold’s Next Price Target is US$2,700,...

August 28, 2024

‘Lighthorse’ Gold Discovery at Pinjin: Thick, High-grade Gold...

February 10, 2025

Rock Chip Results Confirm Polymetallic Potential

March 20, 2025

Recent Posts

  • Appeals court blocks Trump from firing FTC commissioner in case testing president’s removal powers
  • House Oversight Committee releases thousands of Epstein documents
  • Senate advances defense bill boosting service member pay, Pentagon reforms
  • Trump claims Putin, Xi, Kim are conspiring against the US after military parade in China
  • Elon Musk opines on ‘major driver of white males becoming trans’

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (905)
    • Investing (2,886)
    • Politics (3,537)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.